Sun Pharma Seeing Efforts To Speed Up Development For Complex Generics
Indian Firm Enjoys Good Financial Q2, US Formulations Up By More Than 20%
While the firm’s mind and money continues to gear towards branded and novel drugs, India’s Sun Pharma still maintains a mammoth global generics business, including in the US where Sun saw a healthy leap in sales during its financial second quarter.
